Trial Profile
Randomised, Open-label, Multi-Centre, Phase IV Study Assessing the Effect of Oseltamivir Treatment on Cognitive Function in Subjects With Confirmed Influenza Virus Infection.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Mar 2017
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary) ; Antivirals
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Acronyms FOCUS
- 30 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Apr 2012 Planned end date changed from 1 Feb 2012 to 1 May 2012 as reported by ClinicalTrials.gov.
- 05 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.